How Has the Clinical Trial Software Market Size Evolved in Recent Years?
The clinical trial software market has seen considerable growth due to a variety of factors.
• The size of the clinical trial software market has been expanding rapidly over the past few years. The market is projected to escalate from $1.16 billion in 2024 and reach $1.33 billion by 2025, representing a composite annual growth rate (CAGR) of 14.4%.
The significant growth observed previously has been driven by factors such as rising demand for updated software, greater adoption of innovative technologies, swift digitalisation in clinical trials, expanding use of cloud computing, and an upsurge in the number of small to mid-sized biopharmaceutical firms.
What are the Market Size and Expected Growth Rates for the Clinical Trial Software Market Size Evolve over the Forecast Period?
The clinical trial software market is expected to maintain its strong growth trajectory in upcoming years.
• Over the next few years, a steep hike is predicted in the market size of clinical trial software which is expected to reach $2.25 billion by 2029 with an impressive compound annual growth rate (CAGR) of 14.1%.
Several factors influencing this predicted growth during the forecast period include increased clinical research activities, the rising trend of virtual trials, a growing demand for clinical trial solutions that are focused on the patient, an upward trend in the demand for specialty medicines, and a noticeable increase in the prevalence of venous diseases. The projected period will also see key trends such as technology evolution, artificial intelligence (AI), advancements, and innovation in technologies, machine learning in addition to integration with real-world data sources.
What Are the Critical Driver Fuelling The Clinical Trial Software Market's Growth?
The clinical trial software market is predicted to expand as a result of growing research and development activities. These activities, which revolve around investigating, designing, and testing new products or technologies to either enhance current solutions or generate new ones altogether, are on the rise. The surge is being triggered by a heightened demand for innovation in various industries, motivated by technological progress, market competition, and the search for sustainable solutions. This motivates businesses to dedicate more resources towards the creation of new products, processes, and services. Clinical trial software aids these pursuits by facilitating the organization, execution, and administration of clinical trials, essential for the evaluation of new medications and treatments. As an example, the UK government reportedly elevated its investment into research and development in 2022 to £15.5 ($19.67) billion, a 10.5% increase from £14.0 ($17.77) billion in 2021, according to data from the Office for National Statistics in April 2024. Therefore, the surge in research and development activities is fuelling the growth of the clinical trial software market.
What Are The Key Segments Within The Global Clinical Trial Software Market?
The clinical trial software market covered in this report is segmented –
1) By Deployment: On-Premises, Web-Based Clinical Trial Software, Cloud-Based Clinical Trial Software, Other Deployments
2) By Software: Electronic Data Capture (EDC), Electronic Clinical Outcome Assessment (eCOA) Or Electronic Patient-Reported Outcome (ePRO), Electronic Informed Consent
3) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs), Medical Device Manufacturers, Other End-Users
Subsegments:
1) By On-Premises: Enterprise Clinical Trial Management Systems, Site-Based Clinical Trial Solutions
2) By Web-Based Clinical Trial Software: Electronic Data Capture (EDC) Systems, Clinical Trial Management Systems (CTMS), Randomization And Trial Supply Management (RTSM)
3) By Cloud-Based Clinical Trial Software: Software-as-a-Service (SaaS) Platforms, AI-Powered Clinical Trial Solutions, Remote Monitoring And Decentralized Trial Systems
4) By Other Deployments: Hybrid Clinical Trial Solutions, Custom-Built Clinical Trial Software
Pre-Book The Clinical Trial Software Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Clinical Trial Software Market?
Significant businesses participating in the clinical trial software market are prioritizing the advancement of inventive technologies such as unified trial solutions. This focus aims to bolster data collection and integration, refine patient interaction, simplify trial procedures, cut costs, and expedite the general drug evolution process. The Unified Trial Solution is a wide-ranging digital platform custom-built to improve and simplify the clinical trial process. For instance, AstraZeneca plc, a pharmaceutical firm based in the UK, launched Evinova in November 2023 to incorporate AI into clinical studies. This cutting-edge platform includes standout features like automated patient recruitment that uses AI algorithms for rapid alignment of candidates with trial specifications, considerably shortening enrollment durations. It integrates predictive modeling instruments that scrutinize past and real-time data to anticipate patient reactions, thus improving trial design and effectiveness. The platform's accessible interface enhances patient involvement by offering digital communication and feedback platforms, making it easier for participants to express their experiences.
Who Are the Key Players In The Clinical Trial Software Market?
Major companies operating in the clinical trial software market are:
• International Business Machines Corporation
• Oracle Corporation
• Wipro Limited
• Veeva Systems
• Medpace Holdings Inc.
• Medidata Solutions
• Signant Health Inc.
• Clario Inc.
• Advarra Inc.
• Celerion Inc.
• Veristat LLC
• Greenphire Inc.
• Medrio Inc.
• Arisglobal LLC
• Anju Software Inc.
• ClinCapture Inc.
• Palleos Healthcare GmbH
• OpenClinica LLC
• Pharmaseal International Limited
• SoftFormance
What Are The Regional Insights Into The Clinical Trial Software Market?
North America was the largest region in the clinical trial software market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
